Vyome Holdings HIND
NASDAQ HIND
$1.91 +0.00 (+0.00%)
At close: Oct 2, 2026 · 4:00 PM EDT

Vyome Holdings (HIND) Return on Sales [ROS] (2015 - 2026)

Updated

Vyome Holdings (HIND) reported Return on Sales [ROS] of -3200.02% for Q2 2026, down 2551.05 percentage points from -648.98% a year earlier but up 376.76 percentage points from the prior quarter.

Analysis

Vyome Holdings (HIND) Return on Sales [ROS] (2015 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Vyome Holdings' Return on Sales [ROS] came in at -9190.20%, down 8921.45 percentage points year-over-year; for FY2025, it was -3269.35%, down 2877.69 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of -3159.10 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -391.66% in FY2024 (-214.39 pp), -177.26% in FY2023 (+235.11 pp), -412.38% in FY2022 (+13.23 pp) and -425.60% in FY2021 (-315.35 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -24761.92% in Q3 2025 and a high of -95.61% in Q4 2023.
  • Year over year, Return on Sales [ROS] has now declined in each of the last five quarters, with an average year-over-year change of -4344.03 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q4 2022 (a gain of 657.26 percentage points); the low point was Q3 2025 (a drop of 24429.50 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -3576.78% (Q1 2026), -3707.35% (Q4 2025) and -24761.92% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 Vyome Holdings 13.41 Mn -12.70 Mn 11,658.00 -3,200.02%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -3,200.02%
Mar 31, 2026 -3,576.78%
Dec 31, 2025 -3,707.35%
Sep 30, 2025 -24,761.92%
Jun 30, 2025 -648.98%
Mar 31, 2025 -100.21%
Dec 31, 2024 -416.76%
Sep 30, 2024 -332.42%
Jun 30, 2024 -104.53%
Mar 31, 2024 -113.68%
Dec 31, 2023 -95.61%
Sep 30, 2023 -180.05%
Jun 30, 2023 -176.40%
Mar 31, 2023 -246.22%
Dec 31, 2022 -536.75%
Sep 30, 2022 -439.64%
Jun 30, 2022 -319.64%
Mar 31, 2022 -332.50%
Dec 31, 2021 -1,194.02%
Sep 30, 2021 -388.86%
API Access

Vyome Holdings Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=HIND&period=max&api_key=YOUR_API_KEY